All Indian children aged 12 or older will become eligible for Covid-19 vaccinations from next month when drugmaker Cadila Healthcare launches its ZyCoV-D product, two sources with direct knowledge of the matter told.
The world’s first DNA-based Covid-19 vaccine ZyCoV-D won emergency authorization from Indian regulators last month.
From October, the corporate , better known as Zydus Cadila, will produce 10 million doses a month.
The health ministry didn’t immediately respond to a request for comment.
The sources sought anonymity because they weren’t authorized to speak to the media.
The vaccine is that just one approved for kids in India, which has given a total of 825.9 million doses to adults among its population of nearly 1.4 billion.